Stem Cell Theranostics logo — Accelerating therapeutic discovery and enabling personalized...

Stem Cell Theranostics

Accelerating therapeutic discovery and enabling personalized medicine through patient-derived cell models

Founded 2013 11-50 employees Grant Total: $5.65M Biotechnology, Health Care +1

General Information

Company Name Stem Cell Theranostics
Founded Year 2013
Employees 11-50
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Stem Cell Theranostics. To contact Stem Cell Theranostics, visit sctheranostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Stem Cell Theranostics compare?

A PDF of Stem Cell Theranostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Stem Cell Theranostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Stem Cell Theranostics

Stem Cell Theranostics, founded in 2013, is a biotechnology startup with a mission to accelerate therapeutic discovery and enable personalized medicine through patient-derived cell models. The company received a $150.00K grant investment from the National Science Foundation on 17 December 2015. Stem Cell Theranostics operates in the industries of biotechnology, health care, and health and wellness. The company's slogan emphasizes its focus on leveraging cell models for therapeutic advancements.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $150.00K 1
National Science Foundation
17 Dec 2015
Series A $5.50M 1
Bill Marcus
01 Jan 2014

Stem Cell Theranostics Alternatives & Competitors

View All Alternatives
Stem Cell Theranostics vs
Cytocast
Cytocast Hungary

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION

Pre-Seed
19 employees
Biotechnology, Health Care
Stem Cell Theranostics vs
Scailyte
Scailyte Switzerland

True precision medicine through single-cell science.

Series A
18 employees
AI, Biotechnology
Stem Cell Theranostics vs
Kytopen
Kytopen United States

Open cells to new possibilities: Accelerating cell therapy processes from discovery through manufact...

Convertible Note
33 employees
Biotechnology, Health Care

FAQ About Stem Cell Theranostics

Accelerating therapeutic discovery and enabling personalized medicine through patient-derived cell models
Stem Cell Theranostics was founded in 2013.
Stem Cell Theranostics operates in Biotechnology, Health Care and Health and Wellness.
Stem Cell Theranostics has approximately 11-50 employees.
Stem Cell Theranostics has completed 2 funding rounds, raising a total of $5.65M. The latest funding stage is Grant.
Top alternatives and competitors to Stem Cell Theranostics include Cytocast, Scailyte, Kytopen, Kalypsys, Deep Apple Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stem Cell Theranostics and Cytocast are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Stem Cell Theranostics, https://bouncewatch.com/company/stem-cell-theranostics, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes